Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 31, 2016
FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL studyC-H Köhne, G Poston, G Folprecht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2005
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinomaG Folprecht, M P Lutz, P Schöffski, et al.
Cancer Treatment Reviews|December 1, 2009
EORTC Elderly Task Force experts' opinion for the treatment of colon cancer in older patientsA G Pallis, D Papamichael, R Audisio, et al.
Biomolecular Detection and Quantification|January 20, 2018
An optimized targeted Next-Generation Sequencing approach for sensitive detection of single nucleotide variantsS Stasik, C Schuster, C Ortlepp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trialsG Folprecht, D Cunningham, P Ross, et al.
British Journal of Cancer|August 23, 2012
Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trialsA Giatromanolaki, M I Koukourakis, E Sivridis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2018
Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trialR-D Hofheinz, D Arnold, E Fokas, et al.
Pageof 4